Relay Therapeutics Inc (RLAY) — Cash Flow-to-Debt Ratio
Relay Therapeutics Inc (RLAY) has a Cash Flow-to-Debt Ratio of -0.89x as of March 2026, meaning its operating cash flow of $-51.11 Million could theoretically repay -1% of its total liabilities ($57.43 Million) in one year. See Relay Therapeutics Inc (RLAY) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Relay Therapeutics Inc Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Relay Therapeutics Inc across 8 annual periods. Also explore how fast is Relay Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Relay Therapeutics Inc (2018–2025)
Year-by-year debt coverage analysis for Relay Therapeutics Inc. For market capitalisation and broader financial context, see market cap of Relay Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -4.34x | $-235.46 Million | $54.27 Million | ▼ -62.8% |
| 2024 | -2.66x | $-249.11 Million | $93.50 Million | ▲ +18.4% |
| 2023 | -3.27x | $-300.32 Million | $91.98 Million | ▼ -112.8% |
| 2022 | -1.53x | $-229.49 Million | $149.55 Million | ▼ -128.2% |
| 2021 | -0.67x | $-74.41 Million | $110.64 Million | ▲ +76.0% |
| 2020 | -2.81x | $-102.49 Million | $36.54 Million | ▼ -2332.6% |
| 2019 | -0.12x | $-66.13 Million | $573.51 Million | ▼ -41.0% |
| 2018 | -0.08x | $-44.13 Million | $539.54 Million | — |